Estropipate (Avera McKennan Hospital)


Welcome to the PulseAid listing for the Estropipate drug offered from Avera McKennan Hospital. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Avera McKennan Hospital
NON-PROPRIETARY NAME: Estropipate
SUBSTANCE NAME: ESTROPIPATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2016-02-05
END MARKETING DATE: 0000-00-00


Estropipate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionEstropipate from Avera McKennan Hospital
LABELER NAME: Avera McKennan Hospital
DEA SCHEDULE:
ACTIVE STRENGTH: 0.75(mg/1)
START MARKETING DATE: 2016-02-05
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69189-0414_fc03b6a5-4ef3-4bde-8fc2-368cf60732db
PRODUCT NDC: 69189-0414
APPLICATION NUMBER: ANDA081213

Other ESTROPIPATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Estropipate
Avera McKennan HospitalEstropipate
Physicians Total Care, Inc.Estropipate